| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Environmental Health, Occupational Health Program [L. L. X., D. P. M., L. S., D. C. C.] and Biostatistics [S. W. T.], Harvard School of Public Health, Boston, Massachusetts 02115; and Thoracic Surgery Unit, Departments of Surgery [J. C. W.] and Hematology-Oncology [T. J. L.], and Pulmonary and Critical Care Unit, Department of Medicine [D. C. C.], Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114
We conducted a hospital-based case-control study of 814 lung cancer patients and 1123 controls to examine the association of the NAD(P)H: quinone oxidoreductase 1 (NQO1) gene polymorphism with lung cancer susceptibility. Using PCR-RFLP genotyping assay techniques, we analyzed DNA samples to detect the variant forms of the NQO1 gene in exon 6 on chromosome 16q. We examined the relationship between lung cancer odds and NQO1 genotypes after adjusting for age, gender, and smoking behavior using generalized additive modeling. We found no overall association between NQO1 genotypes and lung cancer susceptibility, regardless of age, gender, family history of cancer, or histological cell type. However, our data demonstrated that in both former and current smokers, there was an association between NQO1 genotypes and lung cancer susceptibility that was dependent upon cigarette smoking duration and smoking intensity. For both current and former smokers, smoking intensity was more important in predicting cancer risk than smoking duration for all of the genotypes. Among former smokers, individuals with the T/T genotype were predicted to have a greater cancer risk than those with the C/C genotype for smoking durations up to 37 years. The predicted cancer risk for former smokers with the C/T versus T/T genotype depended on both smoking intensity and smoking duration. Our results support the concept that differential susceptibility to lung cancer is a function of both an inheritable trait in NQO1 metabolism and individual smoking characteristics.
This article has been cited by other articles:
|
|
 |
|
  A. G. Schwartz, G. M. Prysak, C. H. Bock, and M. L. Cote The molecular epidemiology of lung cancer Carcinogenesis, March 1, 2007; 28(3): 507 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chao, Z.-F. Zhang, J. Berthiller, P. Boffetta, and M. Hashibe NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Pro187Ser Polymorphism and the Risk of Lung, Bladder, and Colorectal Cancers: a Meta-analysis. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 979 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Su, W. Zhou, K. Asomaning, X. Lin, J. C. Wain, T. J. Lynch, G. Liu, and D. C. Christiani Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer Carcinogenesis, May 1, 2006; 27(5): 1024 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Thurston, G. Liu, D. P. Miller, and D. C. Christiani Modeling Lung Cancer Risk in Case-Control Studies Using a New Dose Metric of Smoking Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2296 - 2302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Lawson, K. Woodson, J. Virtamo, and D. Albanes Association of the NAD(P)H:Quinone Oxidoreductase (NQO1) 609C->T Polymorphism with Lung Cancer Risk among Male Smokers Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2275 - 2276. [Full Text] [PDF]
|
|
|
|
|
|
L. Su, W. Zhou, S. Park, J. C. Wain, T. J. Lynch, G. Liu, and D. C. Christiani Matrix Metalloproteinase-1 Promoter Polymorphism and Lung Cancer Risk Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 567 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhou, G. Liu, S. Park, Z. Wang, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani Gene-Smoking Interaction Associations for the ERCC1 Polymorphisms in the Risk of Lung Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 491 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.H. Bock, A.S. Wenzlaff, M.L. Cote, S.J. Land, and A.G. Schwartz NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study Carcinogenesis, February 1, 2005; 26(2): 381 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang and G. B. Gordon A strategy for cancer prevention: Stimulation of the Nrf2-ARE signaling pathway Mol. Cancer Ther., July 1, 2004; 3(7): 885 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-K. Alexandrie, F. Nyberg, M. Warholm, and A. Rannug Influence of CYP1A1, GSTM1, GSTT1, and NQO1 Genotypes and Cumulative Smoking Dose on Lung Cancer Risk in a Swedish Population Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 908 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Hung, P. Boffetta, P. Brennan, C. Malaveille, U. Gelatti, D. Placidi, A. Carta, A. Hautefeuille, and S. Porru Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk Carcinogenesis, June 1, 2004; 25(6): 973 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-S. Jeon, K. M. Kim, S. H. Park, S. Y. Lee, J. E. Choi, G. Y. Lee, S. Kam, R. W. Park, I.-S. Kim, C. H. Kim, et al. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer Carcinogenesis, October 1, 2003; 24(10): 1677 - 1681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhou, G. Liu, D. P. Miller, S. W. Thurston, L. L. Xu, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani Polymorphisms in the DNA Repair Genes XRCC1 and ERCC2, Smoking, and Lung Cancer Risk Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 359 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sunaga, T. Kohno, N. Yanagitani, H. Sugimura, H. Kunitoh, T. Tamura, Y. Takei, S. Tsuchiya, R. Saito, and J. Yokota Contribution of the NQO1 and GSTT1 Polymorphisms to Lung Adenocarcinoma Susceptibility Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 730 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hamajima, T. Saito, K. Matsuo, and K. Tajima Competitive Amplification and Unspecific Amplification in Polymerase Chain Reaction with Confronting Two-Pair Primers J. Mol. Diagn., May 1, 2002; 4(2): 103 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. N Ames, I. Elson-Schwab, and E. A Silver High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms Am. J. Clinical Nutrition, April 1, 2002; 75(4): 616 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhou, G. Liu, D. P. Miller, S. W. Thurston, L. L. Xu, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani Gene-Environment Interaction for the ERCC2 Polymorphisms and Cumulative Cigarette Smoking Exposure in Lung Cancer Cancer Res., March 1, 2002; 62(5): 1377 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. I. Wang, D. P. Miller, Y. Sai, G. Liu, L. Su, J. C. Wain, T. J. Lynch, and D. C. Christiani Manganese Superoxide Dismutase Alanine-to-Valine Polymorphism at Codon 16 and Lung Cancer Risk J Natl Cancer Inst, December 5, 2001; 93(23): 1818 - 1821. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
